Activated protein C reduces stress-induced gastric mucosal injury in rats by inhibiting the endothelial cell injury

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 2, 2004, Pages 313-320

  Isobe, H ^a   Okajima, Kenji ^a   Harada, N ^a   Liu, W ^a   Okabe, H ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Activated protein C; Prostacyclin; Tumor necrosis factor

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 10A; MYELOPEROXIDASE; SERINE PROTEINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; PROTECTIVE AGENT; PROTEIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; IMMOBILIZATION STRESS; MALE; MICROVASCULATURE; MUCOSA CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; RAT; STOMACH MUCOSA; STOMACH MUCOSA BLOOD FLOW; STOMACH MUCOSA INJURY; STOMACH PROTECTION; THROMBIN TIME; WATER IMMERSION; ANIMAL; BIOSYNTHESIS; BLOOD FLOW; CAPILLARY PERMEABILITY; DRUG EFFECT; ENDOTHELIUM CELL; LEUKOCYTE ACTIVATION; METABOLISM; PATHOLOGY; STOMACH ULCER; STRESS; WISTAR RAT;

ANIMALS; CAPILLARY PERMEABILITY; ENDOTHELIAL CELLS; GASTRIC MUCOSA; MALE; NEUTROPHIL ACTIVATION; PROTECTIVE AGENTS; PROTEIN C; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW; SERINE ENDOPEPTIDASES; STOMACH ULCER; STRESS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4644349860     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1538-7933.2003.00574.x     Document Type: Article

References (35)

1. Fulcher CA, Gardiner JE, Griffin JH, Zimmerman TS. Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V. Blood 1984; 63: 486-9.
2. Walker FJ, Sexton PW, Esmon CT. The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V. Biochem Biophys Acta 1979; 571: 333-42.
3. Esmon CT. The protein C anticoagulant pathway. Arterioscler Thromb 1992; 12: 135-45.
4. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 1996; 87: 642-7.
5. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol 1997; 272: L197-202.
6. Isobe H, Okajima K, Uchiba M, Mizutani A, Harada N, Nagasaki A, Okabe K. Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Circulation 2001; 104: 1171-5.
7. Mizutani A, Okajima K, Uchiba M, Noguchi T. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 2000; 95: 3781-7.
8. Yuksel M, Okajima K, Uchiba M, Horiuchi S, Okabe H. Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes. Thromb Haemost 2002; 88 267-73.
9. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344 699-709.
10. Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, Winton TL, Rutledge F, Todd TJ, Roy P, Lacroix J, Griffith L, Willan A for The Canadian Critical Care Trials Group. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994; 330: 377-81.
11. Liu W, Okajima K, Murakami K, Harada N, Isobe H, Irie T. Role of neutrophil elastase in stress-induced gastric mucosal injury in rats. J Lab Clin Med 1998; 132: 432-9.
12. Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979; 77: 761-7.
13. 2) in chloralose anesthetized dogs. Br J Pharmacol 1977; 61: 136P.
14. Tateson JE, Moncada S, Vane JR. Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. Prostaglandins 1977; 13: 389-97.
15. 2 on gastric mucosal damage induced by stress, indomethacin and ethanol. Prostaglandins Leukot Essent Fatty Acids 1990; 40: 13-6.
16. Harada N, Okajima K, Liu W, Uchiba M. Activated neutrophils impair gastric cytoprotection role of neutrophil elastase. Dig Dis Sci 2000; 45: 1210-6.
17. Klebanoff SJ, Vadas MA, Harlan JM, Sparks LH, Gamble JR, Agosti JM, Waltersdorph AM. Stimulation of neutrophils by tumor necrosis factor. J Immunol 1986; 136: 4220-5.
18. Okajima K, Koga S, Kaji M, Inoue M, Nakagaki T, Funatsu A, Okabe H, Takatsuki K, Aoki N. Effect of protein C and activated protein C on coagulation and fibrinolysis in normal human subjects. Thromb Haemost 1990; 63: 48-53.
19. Bajaj SP, Rapaport SI, Prodanos CA. A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem 1981; 11: 397-412.
20. Morita T, Jackson CM. Localization of the structural difference between bovine blood coagulation factor X1 and X2 to tyrosine 18 in the activation peptide. J Biol Chem 1986; 261: 4008-14.
21. Grey ST, Tsuchida A, Hau H, Orthner CL, Salem HH, Hancock WW. Selective inhibitory effects of anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-γ, or phorbol ester. J Immunol 1994; 153: 3664-72.
22. Takagi K, Okabe S. The effect of drugs on the production and recovery processes of the stress ulcer. Jpn J Pharmacol 1968; 18 9-18.
23. Wallace JL, Keenan CM, Granger DN. Gastric ulceration induced by nonsteroidal antiinflammatory drugs is neutrophil-dependent process. Am J Physiol 1990; 259: G462-7.
24. Santucci L, Fiorucci S, Giansanti M, Brunori PM, Di Matteo FM, Morlli A. Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumor necrosis factor alpha. Gut 1994; 35: 909-15.
25. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344-50.
26. 2) prevents stress-induced gastric mucosal injury in rats primarily by inhibiting leukocyte activation. Prostaglandins Other Lipid Mediat 1999; 57: 291-303.
27. Redfern JS, Lee E, Feldman M. Effect of indomethacin on gastric mucosal prostaglandins in human. Correlation with mucosal damage. Gastroenterology 1987; 92: 969-77.
28. Murakami K, Okajima K, Uchiba M, Harada N, Liu W, Okabe H, Takatsuki K. Role of granurocyte elastase in indomethacin-induced gastric mucosal lesion formation in rats. J Lab Clin Med 1997; 130: 307-13.
29. Sutton TA, Mang HE, Campos SB, Sandoval RM, Yoder MC, Molitoris BA. Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol 2003; 285: F191-8.
30. Fiske SC. Peptic ulcer disease, cytoprotection, and prostaglandins. Arch Intern Med 1988; 148: 2112-3.
31. Whittle BJR, Kaufmann GL, Boughton-Smith NK. Stimulation of gastric alkaline secretion by stable prostacyclin analogues in rat and dog. Eur J Pharmacol 1984; 100: 277-83.
32. Weksler BB, Jaffe EA, Brower MS, Cole OF. Human leukocyte cathepsin G and elastase specifically suppress thrombin-induced prostacyclin production in human endothelial cells. Blood 1989; 74: 1627-34.
33. Lorant DE, Topham MK, Whatley RE, McEver RP, McIntyre TM, Prescott SM, Zimmerman GA. Inflammatory roles of P-selectin. J Clin Invest 1993; 92: 559-70.
34. Kubes P, Jutila M, Payne D. Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J Clin Invest 1995; 95: 2510-9.
35. Hamaguchi M, Watanabe T, Higuchi K, Tominaga K, Fujiwara Y, Arakawa T. Mechanisms and roles of neutrophil infiltration in stress-induced gastric injury in rats. Dig Dis Sci 2001; 46: 2708-15.